Literature DB >> 16639472

A novel, simple scale for assessing the symptom severity of atrial fibrillation at the bedside: the CCS-SAF scale.

Paul Dorian1, Suzan S Cvitkovic, Charles R Kerr, Eugene Crystal, Anne M Gillis, Peter G Guerra, L Brent Mitchell, Denis Roy, Allan C Skanes, D George Wyse.   

Abstract

BACKGROUND: The severity of symptoms caused by atrial fibrillation (AF) is extremely variable. Quantifying the effect of AF on patient well-being is important but there is no simple, commonly accepted measure of the effect of AF on quality of life (QoL). Current QoL measures are cumbersome and impractical for clinical use.
OBJECTIVE: To create a simple, concise and readily usable AF severity score to facilitate treatment decisions and physician communication.
METHODS: The Canadian Cardiovascular Society (CCS) Severity of Atrial Fibrillation (SAF) Scale is analogous to the CCS Angina Functional Class. The CCS-SAF score is determined using three steps: documentation of possible AF-related symptoms (palpitations, dyspnea, dizziness/syncope, chest pain, weakness/fatigue); determination of symptom-rhythm correlation; and assessment of the effect of these symptoms on patient daily function and QoL. CCS-SAF scores range from 0 (asymptomatic) to 4 (severe impact of symptoms on QoL and activities of daily living). Patients are also categorized by type of AF (paroxysmal versus persistent/permanent). The CCS-SAF Scale will be validated using accepted measures of patient-perceived severity of symptoms and impairment of QoL and will require 'field testing' to ensure its applicability and reproducibility in the clinical setting.
CONCLUSIONS: This type of symptom severity scale, like the New York Heart Association Functional Class for heart failure symptoms and the CCS Functional Class for angina symptoms, trades precision and comprehensiveness for simplicity and ease of use at the bedside. A common language to quantify AF severity may help to improve patient care.

Entities:  

Mesh:

Year:  2006        PMID: 16639472      PMCID: PMC2560532          DOI: 10.1016/s0828-282x(06)70922-9

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  8 in total

1.  ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to develop guidelines for the management of patients with atrial fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology.

Authors:  V Fuster; L E Rydén; R W Asinger; D S Cannom; H J Crijns; R L Frye; J L Halperin; G N Kay; W W Klein; S Lévy; R L McNamara; E N Prystowsky; L S Wann; D G Wyse
Journal:  Eur Heart J       Date:  2001-10       Impact factor: 29.983

2.  2004 Canadian Cardiovascular Society Consensus Conference: Atrial Fibrillation.

Authors: 
Journal:  Can J Cardiol       Date:  2005-09       Impact factor: 5.223

3.  Quality of life in atrial fibrillation: the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.

Authors:  Louise S Jenkins; Michael Brodsky; Eleanor Schron; Mina Chung; Thomas Rocco; Ellis Lader; Martha Constantine; Robert Sheppard; Donald Holmes; Donna Mateski; Liz Floden; Marilyn Prasun; H Leon Greene; Lynn Shemanski
Journal:  Am Heart J       Date:  2005-01       Impact factor: 4.749

4.  Role of gender and personality on quality-of-life impairment in intermittent atrial fibrillation.

Authors:  M Paquette; D Roy; M Talajic; D Newman; A Couturier; C Yang; P Dorian
Journal:  Am J Cardiol       Date:  2000-10-01       Impact factor: 2.778

Review 5.  Quality of life in patients with atrial fibrillation.

Authors:  L S Jenkins; R S Bubien
Journal:  Cardiol Clin       Date:  1996-11       Impact factor: 2.213

6.  Quality of life improves with treatment in the Canadian Trial of Atrial Fibrillation.

Authors:  Paul Dorian; Miney Paquette; David Newman; Martin Green; Stuart J Connolly; Mario Talajic; Denis Roy
Journal:  Am Heart J       Date:  2002-06       Impact factor: 4.749

7.  ACC/AHA key data elements and definitions for measuring the clinical management and outcomes of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Data Standards on Atrial Fibrillation).

Authors:  Robert L McNamara; Lawrence M Brass; Joseph P Drozda; Alan S Go; Jonathan L Halperin; Charles R Kerr; Samuel Lévy; David J Malenka; Suneet Mittal; Frank Pelosi; Yves Rosenberg; Daniel Stryer; D George Wyse; Martha J Radford; David C Goff; Frederick L Grover; Paul A Heidenreich; David J Malenka; Eric D Peterson; Rita F Redberg
Journal:  Circulation       Date:  2004-06-29       Impact factor: 29.690

8.  Asymptomatic arrhythmias in patients with symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia.

Authors:  R L Page; W E Wilkinson; W K Clair; E A McCarthy; E L Pritchett
Journal:  Circulation       Date:  1994-01       Impact factor: 29.690

  8 in total
  23 in total

Review 1.  Symptoms and functional status of patients with atrial fibrillation: state of the art and future research opportunities.

Authors:  Michiel Rienstra; Steven A Lubitz; Saagar Mahida; Jared W Magnani; João D Fontes; Moritz F Sinner; Isabelle C Van Gelder; Patrick T Ellinor; Emelia J Benjamin
Journal:  Circulation       Date:  2012-06-12       Impact factor: 29.690

2.  Evaluation and care of a patient with new-onset atrial fibrillation.

Authors:  Yasbanoo Moayedi; Husam M Abdel-Qadir; Paul Dorian
Journal:  CMAJ       Date:  2013-11-04       Impact factor: 8.262

Review 3.  Atrial Fibrillation Symptoms and Sex, Race, and Psychological Distress: A Literature Review.

Authors:  Kelly T Gleason; Saman Nazarian; Cheryl R Dennison Himmelfarb
Journal:  J Cardiovasc Nurs       Date:  2018 Mar/Apr       Impact factor: 2.083

4.  Symptom challenges after atrial fibrillation ablation.

Authors:  Kathryn A Wood; Angel H Barnes; Sudeshna Paul; Kristina A Hines; Kevin P Jackson
Journal:  Heart Lung       Date:  2017-09-18       Impact factor: 2.210

Review 5.  Challenges in the classification of atrial fibrillation.

Authors:  Steven A Lubitz; Emelia J Benjamin; Jeremy N Ruskin; Valentin Fuster; Patrick T Ellinor
Journal:  Nat Rev Cardiol       Date:  2010-06-22       Impact factor: 32.419

6.  Relation of Body Mass Index to Symptom Burden in Patients withAtrial Fibrillation.

Authors:  Brandon Chalazan; Deanna Dickerman; Arvind Sridhar; Maureen Farrell; Katherine Gayle; David C Samuels; Benjamin Shoemaker; Dawood Darbar
Journal:  Am J Cardiol       Date:  2018-05-01       Impact factor: 2.778

7.  Treating the right patient at the right time: an innovative approach to the management of atrial fibrillation.

Authors:  Anne M Gillis; Laurie Burland; Beverly Arnburg; Cheryl Kmet; P Timothy Pollak; Katherine Kavanagh; George Veenhuyzen; D George Wyse
Journal:  Can J Cardiol       Date:  2008-03       Impact factor: 5.223

8.  [Atrial fibrillation: current recommendations for diagnosis and treatment].

Authors:  P Kirchhof
Journal:  Internist (Berl)       Date:  2013-05       Impact factor: 0.743

9.  The Atrial Fibrillation Therapies after ER visit: Outpatient Care for Patients with Acute AF - The AFTER3 Study.

Authors:  Paul Angaran; Zara Mariano; Vlad Dragan; Lily Zou; Clare L Atzema; Iqwal Mangat; Paul Dorian
Journal:  J Atr Fibrillation       Date:  2015-02-28

10.  Validity and reliability of a new, short symptom rating scale in patients with persistent atrial fibrillation.

Authors:  Marie Härdén; Britta Nyström; Károly Kulich; Jonas Carlsson; Ann Bengtson; Nils Edvardsson
Journal:  Health Qual Life Outcomes       Date:  2009-07-15       Impact factor: 3.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.